The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Support Agreement Arrangements

25 Mar 2009 15:35

RNS Number : 4816P
China Growth Opportunities Ltd
25 March 2009
 



China Growth Opportunities Limited

("China Growth" or "the Company")

New Support Agreement Arrangements

The Board of China Growth is pleased to announce that it has today entered into an agreement with London Asia Capital plc ("London Asia") and London Asia Capital (S) PTE Limited ("LACS") to terminate the Investment Support Agreement dated 7 March 2006 (the "Termination Agreement") and that it has also today entered into a new Asset Divestment Support Agreement with LACS.

Under the Termination Agreement, the Company has agreed to pay £350,000 to London Asia by no later than 31 March 2009. In addition a further sum of £150,000 will be payable to London Asia in the event that China Growth releases its accounts for the year ending 31 March 2009 by no later than 30 June 2009, failing which this sum shall be reduced to £100,000 and payable on 31 July 2009. These payments are in full and final settlement of all sums owing or due to either party and any duties owed by any party to the other. The Company has paid away no fees nor commissions since 30 September 2008 in relation to the Investment Support Agreement dated 7 March 2006.

Under the Termination Agreement, the Company has also agreed a new arrangement with London Asia with effect from 31 March 2009 whereby it will pay London Asia a commission of 5% of the net proceeds of any investments realised as a result of an introduction of a buyer by London Asia or LACS effected after 31 March 2009 subject to the Company agreeing to the sale. 

The Company has also today entered into a new Asset Divestment Support Agreement with LACS whereby LACS will continue to provide the same investment support services to the Company for a fixed fee of £20,000 per month. The new Asset Divestment Support Agreement is terminable on one months' notice by either party, such notice to expire only after six months.

These new arrangements will align the interests of the Company and London Asia more closely in the implementation of the Company's new investment objective.

The Directors estimate that the effect of these agreements is that the Company would currently have pro forma net current assets (being cash balances and other receivables net of all current and accrued liabilities and other provisions) of £4.8 million (30 September 2008; net current liabilities of £0.8 million.). This is currently equivalent to 9.6 pence per share.

With regard to the implementation of the Company's new investment objective, the Board of the Company has initiated the process of selectively soliciting offers for certain of its shareholdings in the investee companies. The Board has also received a number of preliminary approaches from third parties regarding the potential purchase of certain shareholdings in some investee companies. These approaches are at an early stage and discussions have not yet commenced. The Company will report any progress to its shareholders when available. 

Furthermore, the Company is making good progress in the appointment of an Independent Non-Executive Director and expects to make an announcement shortly on this matter.

For further information, please visit www.chinagrowthopportunities.com or contact:

China Growth Opportunities Limited

Rhys Davies

+ 41 (0) 796 200 215

Collins Stewart Europe Limited (Nomad)

Hugh Field

+ 44 (0) 20 7523 8350

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRILFVEVVIEFIA
Date   Source Headline
25th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
18th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
11th Feb 20207:00 amRNSUpdated Key Information Document
31st Jan 20201:30 pmRNSInvestee Company Update: Portage Biotech Inc.
8th Jan 20207:00 amRNSDisposal of Interest in Cryptologic Corp
7th Jan 20207:00 amRNSBoard Appointment
3rd Jan 20201:15 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Dec 20197:00 amRNSHalf-year Report
5th Dec 20192:45 pmRNSTR-1 Notification
19th Nov 20197:00 amRNSLorne Abony appointed as Chairman of EMMAC
16th Oct 20197:00 amRNSInvestee Company Update: EMMAC Life Sciences
15th Oct 20197:00 amRNSInvestee Company Update: Factom inc.
10th Oct 20199:25 amRNSResult of 2019 AGM
27th Sep 20194:31 pmRNSDirector Dealing in the Company
27th Sep 20197:00 amRNSInvestee Company Update : Fralis LLC (Leap Gaming)
26th Sep 201911:21 amRNSInvestee Company Update : Cryptologic Corp
16th Sep 201911:52 amRNSTR-1 Notification of major holdings
11th Sep 20198:00 amRNSResults for the year ended 31st March 2019
11th Sep 20198:00 amRNSNotice of 2019 Annual General Meeting
22nd Aug 201912:01 pmRNSDirectorate Change
19th Aug 20199:23 amRNSJuvenescence closes Series B funding
12th Aug 20193:02 pmRNSInvestee Company Update-Cryptologic issues loan
12th Aug 201910:11 amRNSPortage Trading Suspended
6th Aug 20194:42 pmRNSInvestee Company Update: Cryptologic Corp
30th Jul 201911:07 amRNSSAFE Agreement with Factom, Inc. Extended
25th Jul 20198:17 amRNSFactom Inc SAFE Agreement temporary extension
18th Jul 201911:20 amRNSInvestee Company Update: Regent Pacific on Yooya
16th Jul 20199:13 amRNSInvestee Company Update:EMMAC acquires Terre Verde
11th Jul 20193:00 pmRNSDisposal of interest in Intensity Therapeutics Inc
9th Jul 201910:51 amRNSInvestee Company Update: EMMAC enters new Market
26th Jun 20198:56 amRNSInvestee Company Update: Intensity Therapeutics
29th May 20193:43 pmRNSInvestee Company Update: Offer for Yooya
13th May 201910:21 amRNSDisposal of interest in Vemo Education Inc.
18th Apr 20197:00 amRNSInvestee Company Update: Intensity Therapeutics
4th Apr 20199:51 amRNSTR1 - Correction
3rd Apr 20194:00 pmRNSTR:1 Regent Mercantile Holdings Limited
20th Mar 201911:00 amRNSCompletion of £2 million investment in EMMAC
7th Mar 20194:03 pmRNS£2 million investment in EMMAC Life Sciences
15th Jan 20193:45 pmRNSJuvenescence Series B Funding
3rd Jan 201911:47 amRNSBoard Appointment
12th Dec 201812:52 pmRNSHalf-year Report
3rd Dec 20187:00 amRNSInvestee Company Update: Factom and Yooya
14th Nov 20181:31 pmRNSInvestee Company Update: Factom Inc
22nd Oct 201812:24 pmRNSIntensity Therapeutics Inc Update
12th Sep 20186:12 pmRNSResult of AGM
10th Sep 20189:16 amRNSHolding(s) in Company
22nd Aug 20188:08 amRNSDirector Dealing
3rd Aug 201812:48 pmRNSShareholder update
3rd Aug 20188:00 amRNSPlacing
1st Aug 201812:05 pmRNSResponse to Media Speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.